Back
Regenxbio Vs. Edgewise Therapeutics Industry Stock Comparison
Sell
29
RGNX
Regenxbio
Last Price:
12.49
Seasonality Move:
5.39%
Buy
90
EWTX
Edgewise Therapeutics
Last Price:
29.51
Seasonality Move:
-4.53%
Sell
29
Regenxbio (RGNX)
is a Sell
Is Regenxbio a Buy, Sell or Hold?
- The current Regenxbio [RGNX] share price is $12.50. The Score for RGNX is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
- RGNX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
90
Edgewise Therapeutics (EWTX)
is a Buy
Is Edgewise Therapeutics a Buy, Sell or Hold?
- The current Edgewise Therapeutics [EWTX] share price is $29.50. The Score for EWTX is 90, which is 80% above its historic median score of 50, and infers lower risk than normal.
- EWTX is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
RGNX Stock Price Chart
EWTX Stock Price Chart
What is Edgewise Therapeutics's stock price today?
-
The Edgewise Therapeutics share price today is $29.50
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EWTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
RGNX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.09 | Buy |
| Relative Strength Index (14 RSI): | 52.77 | Buy |
| Chaikin Money Flow: | -575220 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (11.58 - 12.56) | Buy |
| Bollinger Bands (100): | (11.56 - 14.94) | Sell |
EWTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.79 | Buy |
| Relative Strength Index (14 RSI): | 78.49 | Buy |
| Chaikin Money Flow: | 9542700 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (16.59 - 21.35) | Buy |
| Bollinger Bands (100): | (16.57 - 20.61) | Buy |
RGNX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 12.53 | Sell |
| 20-day SMA: | 12.03 | Buy |
| 50-day SMA: | 12.54 | Sell |
| 200-day SMA: | 15.68 | Sell |
| 8-day EMA: | 12.46 | Buy |
| 20-day EMA: | 12.26 | Buy |
| 50-day EMA: | 12.51 | Sell |
| 200-day EMA: | 15 | Sell |
EWTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 19.25 | Buy |
| 20-day SMA: | 18.87 | Buy |
| 50-day SMA: | 18.94 | Buy |
| 200-day SMA: | 16.56 | Buy |
| 8-day EMA: | 20.59 | Buy |
| 20-day EMA: | 19.2 | Buy |
| 50-day EMA: | 18.74 | Buy |
| 200-day EMA: | 16.34 | Buy |
Regenxbio Earnings Growth & RGNX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.42 per share, an increase next quarter of $0.03 per share, an increase this year of $1.03 per share, and an increase next year of $3.83 per share.
Edgewise Therapeutics Earnings Growth & EWTX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.08 per share, an increase this year of $0.05 per share, and a decrease next year of $0.35 per share.
Regenxbio Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Edgewise Therapeutics Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||